Advisory Services Network’s Cellectis CLLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-100
Closed -$2K 1727
2021
Q2
$2K Buy
+100
New +$1.68K ﹤0.01% 3298
2021
Q1
Sell
-100
Closed -$3K 1574
2020
Q4
$3K Hold
100
﹤0.01% 2859
2020
Q3
$2K Buy
+100
New +$1.77K ﹤0.01% 3081
2019
Q4
Sell
-66
Closed -$1K 3101
2019
Q3
$1K Hold
66
﹤0.01% 2695
2019
Q2
$1K Hold
66
﹤0.01% 2693
2019
Q1
$1K Sell
66
-454
-87% -$8.05K ﹤0.01% 2404
2018
Q4
$9K Sell
520
-3,579
-87% -$83K ﹤0.01% 1784
2018
Q3
$116K Hold
4,099
0.01% 923
2018
Q2
$123K Buy
4,099
+21
+0.5% +$625 0.01% 866
2018
Q1
$128K Buy
+4,078
New +$129K 0.01% 933

Other funds holding CLLS

Advisory Services Network's CLLS Position: Q3 2021 in Review

Advisory Services Network sold out of Cellectis (CLLS) in Q3 2021, closing a stake of 100 shares — an estimated $2K sold.

Advisory Services Network first reported a position in CLLS in Q1 2018 and held it in 10 quarters. The position peaked at $128K in Q1 2018. 70 funds tracked by Wall St. Rank hold CLLS as of Q3 2021.

  • Advisory Services Network reported no remaining Cellectis position as of Q3 2021 after selling out during the quarter.
  • Advisory Services Network sold 100 Cellectis shares in Q3 2021, an estimated $2K.
  • Advisory Services Network first reported a position in Cellectis in Q1 2018 and held it in 10 quarters.
  • Advisory Services Network's Cellectis position peaked at $128K in Q1 2018.
  • 70 funds tracked by Wall St. Rank held Cellectis as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.